Digital biomarkers – An Emerging tool in precision Medicines. The Biomarkers Market to Reach $86 Billion by 2027 – Arizton – Yahoo Finance

SIRIUS MANAGEMENT CONSULTING

The global biomarkers market was valued at $45 billion in 2021 and is expected to reach $86 billion by 2027.

Chicago, April 27, 2022 (GLOBE NEWSWIRE) -- According to the latest research report by Arizton, the biomarkers market will grow at a CAGR of over 11% during 2022-2027. Digital biomarkers have become an exciting new tool for advancing precision medicine and supporting clinical trials. They are collected using digital devices that are portable, wearable, implantable, or digestible. Digital biomarkers can be objective, quantifiable, physiological, and behavioral measures. Digital biomarkers have majorly impacted the neurology field. In neurology, several digital biomarkers are being tested for feasibility and reliability in Parkinsons and Alzheimer's disease and clinical outcome assessments.

With the emergence of innovative technologies, the identification and validation of a biomarker are becoming key elements of personalized medicine. For example, in cancer, personalized medicine uses specific biomarker information that has been measured from a persons tumor to help plan treatment regimes, monitor a treatments response, or aid in determining a prognosis.

BIOMARKERS MARKET REPORT SCOPE

REPORT ATTRIBUTE

DETAILS

MARKET SIZE (2027)

$86 Billion

CAGR (2022-2027)

Over 11%

BASE YEAR

2021

FORECAST YEAR

2022-2027

LARGEST MARKET

North America

FASTEST MARKET

Europe

MARKET SEGMENTATION

Indication, Application, Type, and Geography

REGION

North America, Europe, APAC, Latin America, and Middle East & Africa

COUNTRIES COVERED

US, Canada, Germany, France, UK, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia

KEY VENDORS

Abbott, bioMrieux, Biohit Oyj, Centogene, Creative Diagnostics, F. Hoffmann-La Roche, Fujirebio, GE Healthcare, TAmiRNA

Click Here to Download the Free Sample Report

The biomarker approach in developing personalized medicine helps in clinical decisions, personalized therapies, and improved research and development (R&D) models. Developing and providing access to novel personalized medicine products and services are only part of what is needed to achieve better human health by tailoring treatment based on the presence or absence of specific biomarkers.

Story continues

Increased Discovery of Epigenetic Biomarkers in Oncology

Epigenetics, genomic, and epigenomic technologies have opened new and promising landscapes for healthcare professionals, enabling them to diagnose and monitor diseases more precisely, effectively, and rapidly. It is obvious that epigenetics is revolutionizing the potential of biomedicine and clinical diagnostics, therefore, contributing to the future development of precision medicine.

Key Offerings:

Market Size & Forecast by Volume | 20212028

Market Dynamics Leading trends, growth drivers, restraints, and investment opportunities

Market Segmentation A detailed analysis by indication, application, type, and geography

Competitive Landscape 9 key vendors and 22 other vendors

To know more! https://www.arizton.com/market-reports/biomarkers-market

Key Insights

Biomarkers in the field of oncology have revolutionized diagnostics and treatment pathways. Oncology indications constitute of largest share because biomarkers are being largely used for cancer research and diagnostics due to their high prevalence worldwide.

Diagnostics dominated the application segment. However, the application of biomarkers in drug discovery & development is expected to grow significantly during the forecast period because biomarkers studies are expected to become an integral part of the drug development process with the aim of developing more effective drugs at a lower cost

North America is the largest market for biomarkers. The increase in R&D expenditures and funding for biomarker-driven drug discovery & development and precision medicine is one of the major driving factors.

APAC is anticipated to exhibit the highest CAGR of 13.96% during the forecast period. Increasing developments and incorporation of advanced technologies to enhance biomarker-based testing and increasing demand for biomarkers in drug development is driving the demand in APAC.

The COVID-19 pandemic had a negative impact on the market. Several biomarkers research activities got postponed as most of the research activities were focused on COVID-19 indications.

Market Segmentation

Indication

Oncology

Cardiology

Neurology

Immunology

Others

Application

Type

Diagnostic Biomarker

Monitoring Biomarker

Prognostic Biomarker

Predictive Biomarker

Susceptibility Biomarker

Other Biomarker

Region

North America

Europe

Germany

France

UK

Italy

Spain

APAC

Japan

China

India

South Korea

Australia

Latin America

Middle East & Africa

Turkey

South Africa

Saudi Arabia

Competition Overview

The biomarkers market is highly dynamic, with the presence of several global, regional, and local players engaged in biomarkers discovery and development in collaboration with several research organizations. The growth of the biomarkers market majorly depends on advancements in technology and investments in R&D to discover and develop more biomarkers. Global players are focusing on developing more biomarkers and expanding their product portfolio to remain competitive in the market. The key players are also engaged in strategic acquisitions as part of their inorganic growth strategy to remain competitive and grow in the market. Through mergers & acquisitions, major players continue to expand their market shares. Furthermore, they are also growing through partnerships and collaborations with several research organizations to develop biomarkers for new testing strategies.

Explore our healthcare lifesciences profile to know more about the industry.

Click Here to Download the Free Sample Report

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Click Here to Contact Us

Call: +1-312-235-2040+1 302 469 0707

See the rest here:
Digital biomarkers - An Emerging tool in precision Medicines. The Biomarkers Market to Reach $86 Billion by 2027 - Arizton - Yahoo Finance